Immatics (IMTX) FCF Margin (2019 - 2025)

Immatics (IMTX) reported FCF Margin of 291.96% for Q4 2025, down 19099.0% on a YoY basis from N/an in Q4 2024, and up 65.28% sequentially from 840.85% in Q3 2025.

Immatics (IMTX) FCF Margin (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of FCF Margin data on file, last reported at 291.96% in Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 19099.0% year-over-year to 291.96%; the trailing twelve-month figure through Dec 2025 stood at 358.48% (down 26775.0% YoY), and the FY2025 full-year result was 352.36%, down 26139.0% from the prior year.
  • FCF Margin rose to 291.96% in Q4 2025, from 840.85% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 285.75% in Q2 2022 to a low of 840.85% in Q3 2025.
  • A 5-year average of 208.09% and a median of 157.16% in 2022 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin surged 96517 bps in 2022 and sank 77968 bps in 2025, its largest moves.
  • Tracing IMTX's FCF Margin over 5 years: stood at 149.0% in 2021, then advanced by 28 bps to 107.78% in 2022, then surged by 256 bps to 168.16% in 2023, then sank by 160 bps to 100.98% in 2024, then slumped by 189 bps to 291.96% in 2025.
  • Business Quant data shows IMTX's FCF Margin at 291.96% in Q4 2025, 840.85% in Q3 2025, and 794.32% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immatics 1.14 Bn 1.14 Bn - -291.96%

Historic Data

Download Data
DateValue
Dec 31, 2025 -291.96%
Sep 30, 2025 -840.85%
Jun 30, 2025 -794.32%
Mar 31, 2025 -167.53%
Dec 31, 2024 -100.98%
Sep 30, 2024 -61.17%
Jun 30, 2024 -163.14%
Mar 31, 2024 -77.41%
Dec 31, 2023 168.16%
Sep 30, 2023 -405.40%
Jun 30, 2023 18.25%
Mar 31, 2023 -198.02%
Dec 31, 2022 -107.78%
Sep 30, 2022 -151.18%
Jun 30, 2022 285.75%
Mar 31, 2022 105.48%
Dec 31, 2021 -149.00%
Sep 30, 2021 -333.94%
Jun 30, 2021 -679.42%
Mar 31, 2021 -217.37%